Description
4-n-Butylresorcinol (also known as Rucinol) is a potent skin-brightening and anti-hyperpigmentation active widely used in advanced dermatological and cosmetic formulations. Recognized for its strong tyrosinase inhibition properties, it effectively reduces melanin production, helping to lighten dark spots, melasma, age spots, and post-inflammatory hyperpigmentation (PIH).
Compared to many traditional brightening agents, 4-n-Butylresorcinol offers high efficacy at low concentrations, typically between 0.1% and 0.5%, making it suitable for both targeted treatments and overall skin tone correction. It acts on multiple stages of the melanogenesis pathway, providing more comprehensive results than single-mechanism agents like hydroquinone or kojic acid.
This ingredient is often used in serums, creams, and spot treatments designed for evening skin tone and restoring a radiant complexion. It is well tolerated by most skin types when used in appropriate concentrations, though individuals with very sensitive skin should introduce it gradually to avoid mild irritation.
One of the key advantages of 4-n-Butylresorcinol is its stability—it remains effective in a variety of formulations and resists degradation over time, ensuring consistent performance. It can be combined with complementary brightening ingredients such as niacinamide, arbutin, or vitamin C for synergistic effects, as well as sunscreen agents to prevent recurrence of pigmentation.
Extensively studied in dermatology, 4-n-Butylresorcinol has been shown to be more potent than hydroquinone and kojic acid in inhibiting melanin production, while offering a safer profile for long-term use. For best results, it should be used alongside daily broad-spectrum sun protection, as UV exposure is a major trigger for pigmentation disorders.
With its high potency, stability, and safety, 4-n-Butylresorcinol remains a gold-standard active for formulating effective skin-brightening products that deliver visible results in tone uniformity and clarity.
